BioGaia

AGM Information • May 11, 2011

Press Release, 11 May 2011

Annual General Meeting of BioGaia

The Annual General Meeting of BioGaia AB on 10 May 2011 voted to approve the following resolutions:

• a dividend of SEK 2.00 per share
• re-election of Board members Jan Annwall, Stefan Elving, Thomas Flinck, David Dangoor, Inger Holmström, Jörgen Thorball and Paula Zeilon
• re-election of David Dangoor as Board Chairman
• payment of board fees in an amount of SEK 300,000 to the Chairman and SEK 150,000 to each of the other Board members not employed by the company
• auditors' fee shall be paid according to approved account
• regarding principles for remuneration and other terms of employment for senior executives in accordance with the Board's proposal
• regarding the Nominating Committee in accordance with the Nominating Committee's proposal

All decisions that were passed by the Annual General Meeting are consistent with the Board's and Nominating Committee's previously published proposals.

BioGaia has published this information in accordance with the Swedish Securities Market Act. The information was issued for publication on 11 May 2011, 8:00 a.m. CET.

Latest press releases from BioGaia: 2011-05-10 BIoGaia AB Interim report 1 Janjuary – 31 March 2011 2011-04-04 Notice to attend the Annual General Meeting of BioGaia AB 2011-01-14 BioGaia's 50%-owned company TwoPac invests in new facility in Eslöv

For additional information contact: Peter Rothschild, President, telephone: +46 8 -555 293 00 Margareta Hagman, Executive Vice President, telephone: +46 8-555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com